{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:31:51Z","timestamp":1793460711324,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"46","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073043"],"award-info":[{"award-number":["82073043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230100"],"award-info":[{"award-number":["82230100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,12,2]]},"DOI":"10.1038\/s41388-026-04015-0","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:56:25Z","timestamp":1792266985000},"page":"5018-5034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phosphorylation of IRS4 at YY111\/112 promotes LUSC progression via PI3K\/AKT pathway activation"],"prefix":"10.1038","volume":"45","author":[{"given":"Yilixiati","family":"Aihemaiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaideya","family":"Wushaying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9440-7896","authenticated-orcid":false,"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6515-6001","authenticated-orcid":false,"given":"Jianxiu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5033-9622","authenticated-orcid":false,"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"4015_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27:1345\u201356.","journal-title":"Nat Med"},{"key":"4015_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature11404","volume":"489","author":"Cancer Genome Atlas Research Network","year":"2012","unstructured":"Cancer Genome Atlas Research NetworkComprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489:519\u201325.","journal-title":"Nature"},{"key":"4015_CR3","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1158\/1078-0432.CCR-14-3039","volume":"21","author":"DR Gandara","year":"2015","unstructured":"Gandara DR, Hammerman PS, Sos ML, Lara PN, Hirsch FR. Squamous cell lung cancer: from tumor genomics to cancer therapeutics. Clin Cancer Res. 2015;21:2236\u201343.","journal-title":"Clin Cancer Res"},{"key":"4015_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrclinonc.2013.10","volume":"10","author":"J Rodon","year":"2013","unstructured":"Rodon J, Dienstmann R, Serra V, Tabernero J. Development of PI3K inhibitors: lessons learned from early clinical trials. Nat Rev Clin Oncol. 2013;10:143\u201353.","journal-title":"Nat Rev Clin Oncol"},{"key":"4015_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2019","unstructured":"Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2019;20:74\u201388.","journal-title":"Nat Rev Cancer"},{"key":"4015_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0782-4","volume":"17","author":"Z Du","year":"2018","unstructured":"Du Z, Lovly CM. Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer. 2018;17:58.","journal-title":"Mol Cancer"},{"key":"4015_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","volume":"8","author":"S Shyam Sunder","year":"2023","unstructured":"Shyam Sunder S, Sharma UC, Pokharel S. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management. Sig Transduct Target Ther. 2023;8:262.","journal-title":"Sig Transduct Target Ther"},{"key":"4015_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ng.3722","volume":"49","author":"J Weischenfeldt","year":"2016","unstructured":"Weischenfeldt J, Dubash T, Drainas AP, Mardin BR, Chen Y, St\u00fctz AM, et al. Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. Nat Genet. 2016;49:65\u201374.","journal-title":"Nat Genet"},{"key":"4015_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13885-w","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Chen F, Fonseca NA, He Y, Fujita M, Nakagawa H, et al. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations. Nat Commun. 2020;11:736.","journal-title":"Nat Commun"},{"key":"4015_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrm1837","volume":"7","author":"CM Taniguchi","year":"2006","unstructured":"Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006;7:85\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4015_CR11","doi-asserted-by":"publisher","first-page":"21403","DOI":"10.1074\/jbc.272.34.21403","volume":"272","author":"BE Lavan","year":"1997","unstructured":"Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem. 1997;272:21403\u20137.","journal-title":"J Biol Chem"},{"key":"4015_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1478-811X-7-14","volume":"7","author":"K Mardilovich","year":"2009","unstructured":"Mardilovich K, Pankratz SL, Shaw LM. Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun Signal. 2009;7:14.","journal-title":"Cell Commun Signal"},{"key":"4015_CR13","doi-asserted-by":"publisher","first-page":"26908","DOI":"10.1074\/jbc.273.41.26908","volume":"273","author":"MG Myers","year":"1998","unstructured":"Myers MG, Mendez R, Shi P, Pierce JH, Rhoads R, White MF. The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling. J Biol Chem. 1998;273:26908\u201314.","journal-title":"J Biol Chem"},{"key":"4015_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13567","volume":"7","author":"GJ Ikink","year":"2016","unstructured":"Ikink GJ, Boer M, Bakker ERM, Hilkens J. IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K\/AKT-pathway hyperactivation. Nat Commun. 2016;7:13567.","journal-title":"Nat Commun"},{"key":"4015_CR15","doi-asserted-by":"crossref","unstructured":"Guijarro LG, Justo Bermejo FJ, Boaru DL, De Castro-Martinez P, De Leon-Oliva D, Fraile-Mart\u00ednez O, et al. Is insulin receptor substrate4 (IRS4) a platform involved in the activation of several oncogenes? Cancers. 2023;15(18):4651.","DOI":"10.3390\/cancers15184651"},{"key":"4015_CR16","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.1038\/sj.onc.1208721","volume":"24","author":"H Qiu","year":"2005","unstructured":"Qiu H, Zappacosta F, Su W, Annan RS, Miller WT. Interaction between Brk kinase and insulin receptor substrate-4. Oncogene. 2005;24:5656\u201364.","journal-title":"Oncogene"},{"key":"4015_CR17","doi-asserted-by":"crossref","unstructured":"Zhang Y, Xiong X, Zhu Q, Zhang J, Chen S, Wang Y, et al. FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells. Elife. 2022;11:e76183.","DOI":"10.7554\/eLife.76183"},{"key":"4015_CR18","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1006\/bbrc.1999.0967","volume":"260","author":"VR Fantin","year":"1999","unstructured":"Fantin VR, Keller SR, Lienhard GE, Wang LM. Insulin receptor substrate 4 supports insulin- and interleukin 4-stimulated proliferation of hematopoietic cells. Biochem Biophys Res Commun. 1999;260:718\u201323.","journal-title":"Biochem Biophys Res Commun"},{"key":"4015_CR19","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1053\/jhep.2003.50245","volume":"37","author":"O Escribano","year":"2003","unstructured":"Escribano O, Fern\u00e1ndez-Moreno MD, Zueco JA, Menor C, Fueyo J, Ropero RM, et al. Insulin receptor substrate-4 signaling in quiescent rat hepatocytes and in regenerating rat liver. Hepatology. 2003;37:1461\u20139.","journal-title":"Hepatology"},{"key":"4015_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jhep.2007.01.031","volume":"46","author":"EP Cuevas","year":"2007","unstructured":"Cuevas EP, Escribano O, Chiloeches A, Ramirez Rubio S, Rom\u00e1n ID, Fern\u00e1ndez-Moreno MD, et al. Role of insulin receptor substrate-4 in IGF-I-stimulated HEPG2 proliferation. J Hepatol. 2007;46:1089\u201398.","journal-title":"J Hepatol"},{"key":"4015_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07026-5","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Liu Y, Zhao Q, Wang X, Chen X, Hou L, et al. PILRB potentiates the PI3K\/AKT signaling pathway and reprograms cholesterol metabolism to drive gastric tumorigenesis and metastasis. Cell Death Dis. 2024;15:642.","journal-title":"Cell Death Dis"},{"key":"4015_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6:425.","journal-title":"Signal Transduct Target Ther"},{"key":"4015_CR23","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nrc1366","volume":"4","author":"TJ Yeatman","year":"2004","unstructured":"Yeatman TJ. A renaissance for SRC. Nat Rev Cancer. 2004;4:470\u201380.","journal-title":"Nat Rev Cancer"},{"key":"4015_CR24","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1038\/s41388-022-02487-4","volume":"41","author":"SG Pelaz","year":"2022","unstructured":"Pelaz SG, Tabernero A. Src: coordinating metabolism in cancer. Oncogene. 2022;41:4917\u201328.","journal-title":"Oncogene"},{"key":"4015_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.tips.2011.11.002","volume":"33","author":"S Zhang","year":"2011","unstructured":"Zhang S, Yu D. Targeting Src family kinases in anti-cancer therapies: turning promise into triumph. Trends Pharm Sci. 2011;33:122\u20138.","journal-title":"Trends Pharm Sci"},{"key":"4015_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/science.aec1778","volume":"391","author":"CS Delaveris","year":"2026","unstructured":"Delaveris CS, Loudermilk RP, Pandey A, Remesh SG, Peters-Clarke TM, Ganjave SD, et al. Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer. Science. 2026;391:eaec1778.","journal-title":"Science"},{"key":"4015_CR27","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/359336a0","volume":"359","author":"XM Zheng","year":"1992","unstructured":"Zheng XM, Wang Y, Pallen CJ. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Nature. 1992;359:336\u20139.","journal-title":"Nature"},{"key":"4015_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0960-9822(99)80234-6","volume":"9","author":"J Su","year":"1999","unstructured":"Su J, Muranjan M, Sap J. Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Curr Biol. 1999;9:505\u201311.","journal-title":"Curr Biol"},{"key":"4015_CR29","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41388-023-02622-9","volume":"42","author":"J Fang","year":"2023","unstructured":"Fang J, Zhang Y, Huang C, Lu R, Yu J, Chen R, et al. Glucose-mediated N-glycosylation of RPTP\u03b1 affects its subcellular localization and Src activation. Oncogene. 2023;42:1058\u201371.","journal-title":"Oncogene"},{"key":"4015_CR30","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1073\/pnas.94.5.1680","volume":"94","author":"AJ Flint","year":"1997","unstructured":"Flint AJ, Tiganis T, Barford D, Tonks NK. Development of \u201csubstrate-trapping\u201d mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA 1997;94:1680\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4015_CR31","doi-asserted-by":"crossref","unstructured":"Buist A, Blanchetot C, Tertoolen LG, den Hertog J. Identification of p130cas as an in vivo substrate of receptor protein-tyrosine phosphatase alpha. J Biol Chem. 2000;275:20754\u201361.","DOI":"10.1074\/jbc.M001626200"},{"key":"4015_CR32","doi-asserted-by":"crossref","unstructured":"Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 2014;43:12\u2013D520.","DOI":"10.1093\/nar\/gku1267"},{"key":"4015_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.trecan.2019.02.009","volume":"5","author":"J Vallejo-D\u00edaz","year":"2019","unstructured":"Vallejo-D\u00edaz J, Chagoyen M, Olazabal-Mor\u00e1n M, Gonz\u00e1lez-Garc\u00eda A, Carrera AC. The opposing roles of PIK3R1\/p85\u03b1 and PIK3R2\/p85\u03b2 in cancer. Trends Cancer. 2019;5:233\u201344.","journal-title":"Trends Cancer"},{"key":"4015_CR34","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1021\/acs.jctc.7b00125","volume":"13","author":"RF Alford","year":"2017","unstructured":"Alford RF, Leaver-Fay A, Jeliazkov JR, O\u2019Meara MJ, DiMaio FP, Park H, et al. The Rosetta All-Atom Energy Function for Macromolecular Modeling and Design. J Chem Theory Comput. 2017;13:3031\u201348.","journal-title":"J Chem Theory Comput"},{"key":"4015_CR35","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/emboj\/18.9.2459","volume":"18","author":"RA Klinghoffer","year":"1999","unstructured":"Klinghoffer RA, Sachsenmaier C, Cooper JA, Soriano P. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 1999;18:2459\u201371.","journal-title":"EMBO J"},{"key":"4015_CR36","doi-asserted-by":"publisher","first-page":"7906","DOI":"10.1038\/sj.onc.1208160","volume":"23","author":"SJ Parsons","year":"2004","unstructured":"Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene. 2004;23:7906\u20139.","journal-title":"Oncogene"},{"key":"4015_CR37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","volume":"13","author":"SM Thomas","year":"1997","unstructured":"Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997;13:513\u2013609.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4015_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7:48.","journal-title":"Signal Transduct Target Ther"},{"key":"4015_CR39","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/s44318-024-00110-8","volume":"43","author":"Y Wang","year":"2024","unstructured":"Wang Y, Shu H, Qu Y, Jin X, Liu J, Peng W, et al. PKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer. EMBO J. 2024;43:2368\u201396.","journal-title":"EMBO J"},{"key":"4015_CR40","doi-asserted-by":"publisher","first-page":"85063","DOI":"10.18632\/oncotarget.13195","volume":"7","author":"J Vallejo-D\u00edaz","year":"2016","unstructured":"Vallejo-D\u00edaz J, Olazabal-Mor\u00e1n M, Cariaga-Mart\u00ednez AE, Pajares MJ, Flores JM, Pio R, et al. Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma. Oncotarget. 2016;7:85063\u201378.","journal-title":"Oncotarget"},{"key":"4015_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1083\/jcb.200503088","volume":"170","author":"J Luo","year":"2005","unstructured":"Luo J, Field SJ, Lee JY, Engelman JA, Cantley LC. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J Cell Biol. 2005;170:455\u201364.","journal-title":"J Cell Biol"},{"key":"4015_CR42","doi-asserted-by":"publisher","first-page":"55863","DOI":"10.18632\/oncotarget.19866","volume":"8","author":"Y Ito","year":"2017","unstructured":"Ito Y, Vogt PK, Hart JR. Domain analysis reveals striking functional differences between the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), p85\u03b1 and p85\u03b2. Oncotarget. 2017;8:55863\u201376.","journal-title":"Oncotarget"},{"key":"4015_CR43","doi-asserted-by":"publisher","first-page":"11318","DOI":"10.1073\/pnas.1118138109","volume":"109","author":"I Cort\u00e9s","year":"2012","unstructured":"Cort\u00e9s I, S\u00e1nchez-Ru\u00edz J, Zuluaga S, Calvanese V, Marqu\u00e9s M, Hern\u00e1ndez C, et al. p85\u03b2 phosphoinositide 3-kinase subunit regulates tumor progression. Proc Natl Acad Sci USA 2012;109:11318\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4015_CR44","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1038\/sj.onc.1203869","volume":"19","author":"E Ardini","year":"2000","unstructured":"Ardini E, Agresti R, Tagliabue E, Greco M, Aiello P, Yang LT, et al. Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo. Oncogene. 2000;19:4979\u201387.","journal-title":"Oncogene"},{"key":"4015_CR45","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1002\/j.1460-2075.1994.tb06601.x","volume":"13","author":"J den Hertog","year":"1994","unstructured":"den Hertog J, Tracy S, Hunter T. Phosphorylation of receptor protein-tyrosine phosphatase alpha on Tyr789, a binding site for the SH3-SH2-SH3 adaptor protein GRB-2 in vivo. EMBO J. 1994;13:3020\u201332.","journal-title":"EMBO J"},{"key":"4015_CR46","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1111\/febs.13314","volume":"282","author":"X Lai","year":"2015","unstructured":"Lai X, Chen Q, Zhu C, Deng R, Zhao X, Chen C, et al. Regulation of RPTP\u03b1-c-Src signalling pathway by miR-218. FEBS J. 2015;282:2722\u201334.","journal-title":"FEBS J"},{"key":"4015_CR47","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.neo.2017.09.001","volume":"19","author":"J Wang","year":"2017","unstructured":"Wang J, Deng R, Cui N, Zhang H, Liu T, Dou J, et al. Src SUMOylation Inhibits Tumor Growth Via Decreasing FAK Y925 Phosphorylation. Neoplasia. 2017;19:961\u201371.","journal-title":"Neoplasia"},{"key":"4015_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04265-8","volume":"12","author":"J-W Song","year":"2021","unstructured":"Song J-W, Zhu J, Wu X-X, Tu T, Huang J-Q, Chen G-Z, et al. GOLPH3\/CKAP4 promotes metastasis and tumorigenicity by enhancing the secretion of exosomal WNT3A in non-small-cell lung cancer. Cell Death Dis. 2021;12:976.","journal-title":"Cell Death Dis"},{"key":"4015_CR49","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"4015_CR50","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.21105\/joss.04200","volume":"7","author":"M Wojdyr","year":"2022","unstructured":"Wojdyr M. GEMMI: A library for structural biology. J Open Source Softw. 2022;7:4200.","journal-title":"J Open Source Softw"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04015-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04015-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04015-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:06:10Z","timestamp":1793459170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04015-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":50,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2026,12,2]]}},"alternative-id":["4015"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-04015-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9421260\/v1","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee (IACUC) of Shanghai Jiao Tong University School of Medicine(Approval No. SH9H-2022-A372-SB).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}